Site icon Dr. Kara Fitzgerald

Fecal Microbiota Transplant Passes Phase 1 Clinical Trial for Alcohol Use Disorder

Fecal Microbiota Transplant Passes Phase 1 Clinical Trial for Alcohol Use Disorder

This phase 1 trial shows that FMT is safe and associated with short-term reduction in alcohol craving and consumption with favorable microbial changes versus placebo in patients with alcohol-related cirrhosis with alcohol misuse. There was also a reduction in AUD-related events over 6 months in patients assigned to FMT.”

FMT = fecal microbiota transplant / AUD = alcohol use disorder

What a compelling indication of how our microbiome influences our choices, behaviors and health. And an important finding for alcohol abuse treatment.

https://pubmed.ncbi.nlm.nih.gov/32750174/

 

Exit mobile version